Patents Assigned to BioBlast Pharma Ltd.
  • Compositions and methods for treating huntington's disease
    Patent number: 9572825
    Abstract: The present invention provides intravenous compositions of trehalose for the treatment of signs and symptoms of Huntington's disease.
    Type: Grant
    Filed: August 5, 2015
    Date of Patent: February 21, 2017
    Assignee: BioBlast Pharma Ltd.
    Inventor: Dalia Megiddo
  • TREATMENT OF PROTEIN AGGREGATION MYOPATHIC AND NEURODEGENERATIVE DISEASES BY PARENTERAL ADMINISTRATION OF TREHALOSE
    Publication number: 20160120798
    Abstract: Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose. Also disclosed is an injectable aqueous pharmaceutical formulation comprising a therapeutically effective amount of trehalose.
    Type: Application
    Filed: May 7, 2014
    Publication date: May 5, 2016
    Applicant: BioBlast Pharma Ltd.
    Inventor: Dalia MEGIDDO
  • Compositions and methods for treating spinocerebellar ataxia
    Patent number: 9125924
    Abstract: The present invention provides intravenous compositions of trehalose for the treatment of signs and symptoms of spinocerebellar ataxia (SCA).
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: September 8, 2015
    Assignee: BioBlast Pharma LTD.
    Inventor: Dalia Megiddo
  • Compositions and methods for treating oculopharyngeal muscular dystrophy
    Patent number: 9084720
    Abstract: The present invention provides intravenous compositions of trehalose for the treatment of signs and symptoms of oculopharyngeal muscular dystrophy (OPMD).
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: July 21, 2015
    Assignee: BioBlast Pharma Ltd.
    Inventor: Dalia Megiddo
  • Mitochondrial proteins constructs and uses thereof
    Patent number: 8912147
    Abstract: The invention provides fusion protein constructs comprising a functional mitochondrial protein and methods of treating mitochondrial disorders by the fusion proteins and compositions thereof.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: December 16, 2014
    Assignee: BioBlast Pharma Ltd.
    Inventor: Haya Lorberboum-Galski